Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-05

FDA Approved: FENOFIBRATE — Supplemental Application (AvKARE)

View source ↗

Summary

FDA approved a supplemental application for fenofibrate from AvKARE, granting approval for a change under the ANDA for this generic product. This marks a regula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)